Biosimilars in rheumatology: pharmacological and pharmacoeconomic issues
- Author
- LAPADULA, G1 2 ; FERRACCIOLI, G. F1 2
[1] Rheumatology Unit - DiMIMP, University of Bari, Bari, Italy
[2] Institute of Rheumatology and Affine Sciences (IRSA), Catholic University of the Sacred Heart - CIC, Rome, Italy - Issue title
- Treat-to-target in Rheumatoid Arthritis: Clinical and Pharmacoeconomic Considerations
- Author (monograph)
- TURCHETTI, G (Editor); SMOLEN, J. S (Editor); KAVANAUGH, A (Editor); BRAUN, J (Editor); PINCUS, T (Editor)
- Source
Clinical and experimental rheumatology (Testo stampato). 2012, Vol 30, Num 4 ; S102-S106 ; SUP73 ; ref : 20 ref
- ISSN
- 0392-856X
- Scientific domain
- Rheumatology
- Publisher
- Clinical and Experimental Rheumatology, Pisa
- Publication country
- Italy
- Document type
- Article
- Language
- English
- Author keyword
- bioequivalence biosimilar immunogenicity interchangeability
- Keyword (fr)
- Immunogénicité Rhumatologie
- Keyword (en)
- Immunogenicity Rheumatology
- Keyword (es)
- Inmunogenicidad Reumatología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B15 Diseases of the osteoarticular system
- Discipline
- Osteoarticular pathology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 27312989
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:72:\"Biosimilars in rheumatology: pharmacological and pharmacoeconomic issues\";s:9:\"\u0000*\u0000jtitle\";s:55:\"Clinical and experimental rheumatology (Testo stampato)\";s:9:\"\u0000*\u0000stitle\";s:36:\"Clin. exp. rheumatol. (Testo stamp.)\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:0:\"\";s:8:\"\u0000*\u0000epage\";s:0:\"\";s:8:\"\u0000*\u0000pages\";s:9:\"S102-S106\";s:7:\"\u0000*\u0000issn\";s:9:\"0392-856X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"LAPADULA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:17:\"FERRACCIOLI, G. F\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:5:\"SUP73\";s:9:\"\u0000*\u0000btitle\";s:85:\"Treat-to-target in Rheumatoid Arthritis: Clinical and Pharmacoeconomic Considerations\";s:8:\"\u0000*\u0000title\";s:72:\"Biosimilars in rheumatology: pharmacological and pharmacoeconomic issues\";s:8:\"\u0000*\u0000place\";s:4:\"Pisa\";s:6:\"\u0000*\u0000pub\";s:38:\"Clinical and Experimental Rheumatology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:72:\"Biosimilars in rheumatology: pharmacological and pharmacoeconomic issues\";s:9:\"\u0000*\u0000jtitle\";s:55:\"Clinical and experimental rheumatology (Testo stampato)\";s:9:\"\u0000*\u0000stitle\";s:36:\"Clin. exp. rheumatol. (Testo stamp.)\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:0:\"\";s:8:\"\u0000*\u0000epage\";s:0:\"\";s:8:\"\u0000*\u0000pages\";s:9:\"S102-S106\";s:7:\"\u0000*\u0000issn\";s:9:\"0392-856X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"LAPADULA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:17:\"FERRACCIOLI, G. F\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:5:\"SUP73\";s:9:\"\u0000*\u0000btitle\";s:85:\"Treat-to-target in Rheumatoid Arthritis: Clinical and Pharmacoeconomic Considerations\";s:8:\"\u0000*\u0000title\";s:72:\"Biosimilars in rheumatology: pharmacological and pharmacoeconomic issues\";s:8:\"\u0000*\u0000place\";s:4:\"Pisa\";s:6:\"\u0000*\u0000pub\";s:38:\"Clinical and Experimental Rheumatology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:72:\"Biosimilars in rheumatology: pharmacological and pharmacoeconomic issues\";s:9:\"\u0000*\u0000jtitle\";s:55:\"Clinical and experimental rheumatology (Testo stampato)\";s:9:\"\u0000*\u0000stitle\";s:36:\"Clin. exp. rheumatol. (Testo stamp.)\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:0:\"\";s:8:\"\u0000*\u0000epage\";s:0:\"\";s:8:\"\u0000*\u0000pages\";s:9:\"S102-S106\";s:7:\"\u0000*\u0000issn\";s:9:\"0392-856X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"LAPADULA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:17:\"FERRACCIOLI, G. F\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:5:\"SUP73\";s:9:\"\u0000*\u0000btitle\";s:85:\"Treat-to-target in Rheumatoid Arthritis: Clinical and Pharmacoeconomic Considerations\";s:8:\"\u0000*\u0000title\";s:72:\"Biosimilars in rheumatology: pharmacological and pharmacoeconomic issues\";s:8:\"\u0000*\u0000place\";s:4:\"Pisa\";s:6:\"\u0000*\u0000pub\";s:38:\"Clinical and Experimental Rheumatology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:72:\"Biosimilars in rheumatology: pharmacological and pharmacoeconomic issues\";s:9:\"\u0000*\u0000jtitle\";s:55:\"Clinical and experimental rheumatology (Testo stampato)\";s:9:\"\u0000*\u0000stitle\";s:36:\"Clin. exp. rheumatol. (Testo stamp.)\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:0:\"\";s:8:\"\u0000*\u0000epage\";s:0:\"\";s:8:\"\u0000*\u0000pages\";s:9:\"S102-S106\";s:7:\"\u0000*\u0000issn\";s:9:\"0392-856X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"LAPADULA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:17:\"FERRACCIOLI, G. F\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:5:\"SUP73\";s:9:\"\u0000*\u0000btitle\";s:85:\"Treat-to-target in Rheumatoid Arthritis: Clinical and Pharmacoeconomic Considerations\";s:8:\"\u0000*\u0000title\";s:72:\"Biosimilars in rheumatology: pharmacological and pharmacoeconomic issues\";s:8:\"\u0000*\u0000place\";s:4:\"Pisa\";s:6:\"\u0000*\u0000pub\";s:38:\"Clinical and Experimental Rheumatology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:72:\"Biosimilars in rheumatology: pharmacological and pharmacoeconomic issues\";s:9:\"\u0000*\u0000jtitle\";s:55:\"Clinical and experimental rheumatology (Testo stampato)\";s:9:\"\u0000*\u0000stitle\";s:36:\"Clin. exp. rheumatol. (Testo stamp.)\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"30\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:0:\"\";s:8:\"\u0000*\u0000epage\";s:0:\"\";s:8:\"\u0000*\u0000pages\";s:9:\"S102-S106\";s:7:\"\u0000*\u0000issn\";s:9:\"0392-856X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"LAPADULA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:17:\"FERRACCIOLI, G. F\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:5:\"SUP73\";s:9:\"\u0000*\u0000btitle\";s:85:\"Treat-to-target in Rheumatoid Arthritis: Clinical and Pharmacoeconomic Considerations\";s:8:\"\u0000*\u0000title\";s:72:\"Biosimilars in rheumatology: pharmacological and pharmacoeconomic issues\";s:8:\"\u0000*\u0000place\";s:4:\"Pisa\";s:6:\"\u0000*\u0000pub\";s:38:\"Clinical and Experimental Rheumatology\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
